Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Skye Bioscience, Inc. - Common Stock
(NQ:
SKYE
)
0.6980
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Skye Bioscience, Inc. - Common Stock
< Previous
1
2
Next >
These stocks have an unusual volume in today's session
↗
March 11, 2026
Via
Chartmill
What's going on in today's pre-market session
↗
March 11, 2026
Via
Chartmill
Get insights into the top gainers and losers of Tuesday's after-hours session.
↗
March 10, 2026
Via
Chartmill
Which stocks are moving after the closing bell on Tuesday?
↗
December 23, 2025
After the conclusion of the US market's regular session on Tuesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
Earnings Scheduled For November 10, 2025
↗
November 10, 2025
Via
Benzinga
Earnings Scheduled For August 7, 2025
↗
August 07, 2025
Via
Benzinga
What One Fund's Sale of Centessa Stock Signals About the Fast-Rising Biotech Company
↗
November 29, 2025
Here's why a fast-rising pharmaceutical trimmed—and not abandoned—by a specialist fund signals ongoing conviction in the stock.
Via
The Motley Fool
Topics
Regulatory Compliance
5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity?
↗
November 18, 2025
One major biotech investor just walked away from Viking Therapeutics. Here’s what the move may—and may not—mean for the company’s clinical-stage future.
Via
The Motley Fool
Topics
Regulatory Compliance
5AM Venture Bails on MoonLake After a Brutal Year: Here’s What Stands Out
↗
November 18, 2025
A major biotech investor just walked away from MoonLake after a rough year for the stock. Here’s what that move signals—and what long-term investors should keep an eye on next.
Via
The Motley Fool
Insights Ahead: Skye Bioscience's Quarterly Earnings
↗
November 07, 2025
Via
Benzinga
The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things.
↗
November 07, 2025
The feast that saw obesity-tied stocks skyrocket in 2024 is over. Investors' appetite for weight-loss drugs has waned.
Via
Investor's Business Daily
Topics
Government
These stocks are moving in today's session
↗
October 06, 2025
Here are the top movers in Monday's session, showcasing the stocks with significant price changes.
Via
Chartmill
Nasdaq Jumps Over 150 Points; Skye Bioscience Shares Plunge
↗
October 06, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
October 06, 2025
Via
Benzinga
Let's take a look at the stocks that are in motion in today's session.
↗
October 06, 2025
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
US Stocks Mixed; Dow Falls 100 Points
↗
October 06, 2025
Via
Benzinga
Topics
Stocks
Skye Bioscience's Investigational Drug Disappoints As Monotherapy For Weight Loss
↗
October 06, 2025
Skye Bioscience'a trial showed nimacimab alone missed goals, while a combo with Novo Nordisk's drug delivered stronger weight loss results.
Via
Benzinga
Monday's session: gap up and gap down stocks
↗
October 06, 2025
The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via
Chartmill
Why AMD Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket
↗
October 06, 2025
Via
Benzinga
Wondering what's happening in today's pre-market session?
↗
October 06, 2025
Discover the top movers in Monday's pre-market session and stay informed about market dynamics.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
October 06, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
September 26, 2025
Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of their outstanding shares is at $165.6 million.
Via
Benzinga
Could This New Drug Be The Safer Way To Fight Obesity?
↗
September 19, 2025
Skye Bioscience reported favorable Phase 1b nimacimab results, with analysts citing strong potential in obesity alongside GLP-1 therapies.
Via
Benzinga
Skye Bioscience Advances Position In Competitive Obesity Market With Promising Data
↗
September 05, 2025
Skye Bioscience's latest data show nimacimab boosted tirzepatide's weight loss effects and reduced obesity treatment rebound risk.
Via
Benzinga
Skye (SKYE) Q2 R&D Soars 249% No Revenue
↗
August 07, 2025
Via
The Motley Fool
Topics
Intellectual Property
In today's session, these stocks are experiencing unusual volume.
↗
June 24, 2025
Which stocks have an unusual volume on Tuesday?
Via
Chartmill
What's going on in today's session
↗
June 23, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
June 23, 2025
Via
Benzinga
Which stocks are experiencing notable movement on Monday?
↗
June 23, 2025
Stay up-to-date with the latest market trends in the middle of the day on Monday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
These stocks are moving in today's pre-market session
↗
June 23, 2025
Discover the top movers in Monday's pre-market session and stay informed about market dynamics.
Via
Chartmill
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
